Whitt, Michael A (2010) Generation of VSV pseudotypes using recombinant ?G-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J Virol Methods 169:365-74
|
Perez, Mar; Clemente, Roberto; Robison, Clinton S et al. (2007) Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus. J Virol 81:5527-36
|
Klas, Sheri D; Lavine, Christy L; Whitt, Michael A et al. (2006) IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors. Vaccine 24:1451-61
|
Duntsch, Christopher D; Zhou, Qihong; Jayakar, Himangi R et al. (2004) Recombinant vesicular stomatitis virus vectors as oncolytic agents in the treatment of high-grade gliomas in an organotypic brain tissue slice-glioma coculture model. J Neurosurg 100:1049-59
|
Pinschewer, Daniel D; Perez, Mar; Jeetendra, Eswaraka et al. (2004) Kinetics of protective antibodies are determined by the viral surface antigen. J Clin Invest 114:988-93
|
Miller, Mark A; Lavine, Christy L; Klas, Sheri D et al. (2004) Recombinant replication-restricted VSV as an expression vector for murine cytokines. Protein Expr Purif 33:92-103
|
Jeetendra, E; Ghosh, Kakoli; Odell, Derek et al. (2003) The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity. J Virol 77:12807-18
|
Klas, Sheri D; Robison, Clinton S; Whitt, Michael A et al. (2002) Adjuvanticity of an IL-12 fusion protein expressed by recombinant deltaG-vesicular stomatitis virus. Cell Immunol 218:59-73
|
Jeetendra, E; Robison, Clinton S; Albritton, Lorraine M et al. (2002) The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. J Virol 76:12300-11
|
Matsuura, Y; Tani, H; Suzuki, K et al. (2001) Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286:263-75
|
Showing the most recent 10 out of 18 publications